Source: Bollettino Chimico Farmaceutico. Conference titles: Congress of Pharmaceutical Sciences. Unidades: FCFRP, FCF
Assunto: FARMACOLOGIA
ABNT
MATEUS, F H et al. Enantioselectivity of 4-hydroxylation in hypertensive patients phenotyped as extensive metabolizers of debrisoquine. Bollettino Chimico Farmaceutico. Milano: Societá Editoriale Farmaceutica. . Acesso em: 30 set. 2024. , 1999APA
Mateus, F. H., Cerqueira, P. M., Bonato, P. S., Cesarino, E. J., Mere Júnior, Y., Santos, S. R. C. J., & Lanchote, V. L. (1999). Enantioselectivity of 4-hydroxylation in hypertensive patients phenotyped as extensive metabolizers of debrisoquine. Bollettino Chimico Farmaceutico. Milano: Societá Editoriale Farmaceutica.NLM
Mateus FH, Cerqueira PM, Bonato PS, Cesarino EJ, Mere Júnior Y, Santos SRCJ, Lanchote VL. Enantioselectivity of 4-hydroxylation in hypertensive patients phenotyped as extensive metabolizers of debrisoquine. Bollettino Chimico Farmaceutico. 1999 ; 132( 2): CCXXX.[citado 2024 set. 30 ]Vancouver
Mateus FH, Cerqueira PM, Bonato PS, Cesarino EJ, Mere Júnior Y, Santos SRCJ, Lanchote VL. Enantioselectivity of 4-hydroxylation in hypertensive patients phenotyped as extensive metabolizers of debrisoquine. Bollettino Chimico Farmaceutico. 1999 ; 132( 2): CCXXX.[citado 2024 set. 30 ]